市場調査レポート

商品コード

1792308

ハイコンテントスクリーニング市場レポート：製品、用途、エンドユーザー、地域別、2025～2033年

High Content Screening Market Report by Product, Application, End-User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations ), and Region 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 448,260円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 597,730円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 747,200円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.47円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のハイコンテントスクリーニング市場規模は2024年に14億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに27億米ドルに達し、2025年から2033年にかけて7.13％の成長率（CAGR）を示すと予測しています。同市場は、統合イメージング技術の利用による創薬アプリケーションの急速な進歩、製薬研究への投資の高まり、時間とコストを最小限に抑えながらスクリーニングを行う手法への需要の高まり、ラボにおける自動化システムの確立などにより、大きな成長を遂げています。

ハイコンテントスクリーニング市場分析：

主な市場促進要因ハイコンテントスクリーニング市場の成長は、創薬や市場開拓による需要の拡大、ハイスループット生産を特徴とするイメージング技術の進歩、医薬品やバイオテクノロジー研究への大規模な投資配分によって大きく牽引されています。また、活性薬剤候補の同定と理解を助ける迅速で生産性の高いスクリーニング技術に対する需要も市場成長に拍車をかけています。
主な市場動向：市場動向には、データ解析を利用したAIや機械学習アルゴリズムの急速なデジタル化、より生理学的に適切な結果をもたらす3D細胞モデルの取り込み、さまざまな細胞モデルに対するマルチパラダイムアッセイの市場開拓などが含まれます。
地理的動向：製薬・バイオテクノロジー産業の急速な開拓、研究開発への継続的な投資、市場の主要プレーヤーや学術研究機関の存在につながる高度なヘルスケアインフラにより、北米が市場を独占しています。
競合情勢：業界の主要な市場プレーヤーには、Becton, Dickinson and Company、Bio-Rad Laboratories Inc.、Biotek Instruments Inc.、Danaher Corporation、GEヘルスケア、Merck Millipore、Perkinelmer Inc.、Tecan Group Ltd.、Thermo Fisher Scientific、横河電機などがあります。
課題と機会：同市場は、装置や試薬の高コスト、データ解析や標準の複雑さといった課題に直面しています。一方、新たな革新的イメージング技術の開発や創薬以外の応用範囲の拡大、研究開発における産学共同研究の容易化など、ハイコンテントスクリーニング市場には大きなビジネスチャンスがあります。

ハイコンテントスクリーニング市場動向：

創薬需要の増加

市場は主に、迅速かつ効果的な創薬アプローチに対するニーズの高まりによって牽引されています。例えば、NIHの報告によると、世界の医薬品市場は2025年にはほぼ倍増し、1兆5,000億米ドルに達すると予想されており、高度なスクリーニング技術が求められています。HCSは、多くのパラメーターを同時に分析し、潜在的な医薬品候補を早期に特定することを可能にします。その結果、製薬会社はHCSに信頼を置かざるを得なくなり、その結果、調査市場規模は拡大し、創薬プロセスも改善されます。

イメージング技術の継続的な進歩：

画像技術は企業によって継続的に開発されており、より正確で詳細かつ専門的な診断ツールの提供に役立っています。例えば、全米科学財団（NSF）の報告書によると、年間成長率は6.2％であり、これは細胞分析のハイコンテントスクリーニングに応用するために、より多くの研究室が先進的な画像診断モダリティのオペレーターを採用していることを意味しています。研究者は現在、超解像顕微鏡、共焦点イメージング、ライブセルイメージング設備によって、細胞の構造や働きをリアルタイムで高画質画像化することができます。このような技術革新により、ハイコンテントスクリーニングシステムは、分析精度が向上し、より詳細な結果が得られるようになります。そのため、最新のイメージング技術を取り入れた、よりクリーンで効率的なハイコンテントスクリーニングシステムの供給が増加しており、市場開拓の要因となっています。

バイオテクノロジー研究への投資増加

ハイコンテントスクリーニング市場の収益は、世界中でバイオテクノロジーへの投資が増加しているため、大きな成長を遂げています。バイオテクノロジー革新機構（BIO）によると、バイオテクノロジー研究開発への世界の支出は2020年に2,100億米ドルを超え、科学的知識の向上や新しい治療法の開発に投資が行われていることを示しています。ハイコンテントスクリーニングは、細胞が何をするのか、分子間の相互作用はどうなっているのかという調査プロセスを加速させることで、バイオテクノロジー研究の中心的な位置を占めています。バイオテクノロジー企業や研究機関は、医薬品開発のために新たな創薬標的を利用し、化合物の有効性や毒性を評価し、疾患メカニズムを解明することが、ハイコンテントスクリーニング市場の需要を増加させる要因の一つとなっています。その結果、この傾向は市場の成長につながり、ハイコンテントスクリーニング技術のさらなる研究が行われるでしょう。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場内訳：国別

第10章 SWOT分析

概要
強み
弱み
機会
脅威

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第13章価格指標

第14章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Becton, Dickinson and Company
- Bio-Rad Laboratories Inc.
- Biotek Instruments Inc.
- Danaher Corporation
- GE Healthcare
- Merck Millipore
- Perkinelmer Inc.
- Tecan Group Ltd.
- Thermo Fisher Scientific
- Yokogawa Electric Corporation

図表

List of Figures

Figure 1: Global: High Content Screening Market: Major Drivers and Challenges
Figure 2: Global: High Content Screening Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: High Content Screening Market: Breakup by Product (in %), 2024
Figure 4: Global: High Content Screening Market: Breakup by Application (in %), 2024
Figure 5: Global: High Content Screening Market: Breakup by End-User (in %), 2024
Figure 6: Global: High Content Screening Market: Breakup by Region (in %), 2024
Figure 7: Global: High Content Screening Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 8: Global: High Content Screening (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: High Content Screening (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: High Content Screening (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: High Content Screening (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: High Content Screening (Software) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: High Content Screening (Software) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: High Content Screening (Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: High Content Screening (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: High Content Screening (Accessories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: High Content Screening (Accessories) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: High Content Screening (Target Identification and Validation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: High Content Screening (Target Identification and Validation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: High Content Screening (Primary Screening and Secondary Screening) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: High Content Screening (Primary Screening and Secondary Screening) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: High Content Screening (Toxicity Studies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: High Content Screening (Toxicity Studies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: High Content Screening (Compound Profiling) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: High Content Screening (Compound Profiling) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: High Content Screening (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: High Content Screening (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: High Content Screening (Academic and Government Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: High Content Screening (Academic and Government Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: High Content Screening (Contract Research Organizations-CROs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: High Content Screening (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: North America: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: North America: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: United States: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: United States: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Canada: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Canada: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Asia Pacific: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Asia Pacific: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: China: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: China: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Japan: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Japan: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: India: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: India: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: South Korea: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: South Korea: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Australia: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Australia: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Indonesia: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Indonesia: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Others: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Others: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Europe: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Europe: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Germany: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Germany: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: France: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: France: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: United Kingdom: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: United Kingdom: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Italy: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Italy: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Spain: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Spain: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Russia: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Russia: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Others: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Others: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Latin America: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Latin America: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Brazil: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Brazil: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Mexico: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Mexico: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Others: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Others: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Middle East and Africa: High Content Screening Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Middle East and Africa: High Content Screening Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Global: High Content Screening Industry: SWOT Analysis
Figure 83: Global: High Content Screening Industry: Value Chain Analysis
Figure 84: Global: High Content Screening Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: High Content Screening Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: High Content Screening Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: High Content Screening Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: High Content Screening Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 5: Global: High Content Screening Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: High Content Screening Market: Competitive Structure
Table 7: Global: High Content Screening Market: Key Players

Product Code: SR112025A1988

The global high content screening market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.7 Billion by 2033, exhibiting a growth rate (CAGR) of 7.13% during 2025-2033. The market is experiencing significant growth driven by rapid advancements in drug discovery applications through the use of integrated imaging technologies, heightening investments in pharmaceutical research, escalating demand for a screening method while minimizing time and cost, and the establishment of automated system in laboratories.

High Content Screening Market Analysis:

Major Market Drivers: The high content screening market growth is driven largely by the growing demand from drug discovery and development, progress in imaging technologies featuring high-throughput production, and large investments allocation to pharmaceuticals and biotechnology studies. Besides, the demand for expeditious and productive screening techniques, aiding the identification and understanding of active drug candidates, also adds fuel to the market growth.
Key Market Trends: The market trends include the rapid digitization of AI and machine learning algorithms that use data analysis, incorporating 3D cell models that produce more physiologically relevant results, and the development of multiparadigm assays for various cellular models.
Geographical Trends: North America dominate the market due to rapid development in the pharmaceutical and biotechnology industries, ongoing investments in research and development, advanced healthcare infrastructure which connects to the presence of market key players and academic research institutions.
Competitive Landscape: Some of the major market players in the industry include Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific, Yokogawa Electric Corporation, among many others.
Challenges and Opportunities: The market faces challenges such as the high cost of equipment and reagents, the complexity of data analysis and standards. On the other hand, high content screening market opportunities are enormous in terms of developing new innovative imaging technologies or broadening their range of applications beyond drug discovery and making collaborative studies between academia and industry easier for research and development.

High Content Screening Market Trends:

Increasing Demand for Drug Discovery:

The market is primarily driven by the increasing need for fast and effective drug discovery approaches. For instance, NIH reports that the global pharmaceutical market is anticipated to almost double and stand at 1.5 trillion dollars in 2025 thus urging for advanced screening technologies. HCS in turn enables the analyses of many parameters at the same time and the earlier identification of potential drug candidates, hence allowing shorter time to develop them. As a result, pharmaceutical organizations are forced to put their trust in HCSs which consequently makes the research market size larger and improves the discovery process of drugs.

Ongoing Advancements in Imaging Technologies:

The imaging technologies are continuously developed by companies, that help to provide more accurate, detailed, and specialized diagnostic tools, creating a positive high content screening market outlook. For instance, the National Science Foundation (NSF) report shows the annual growth of 6.2%, which means more and more laboratories are adopting the operatories of advanced imaging modalities for application in high content screening of cellular analysis. Researchers can now make high-quality images of the structures and workings of cells in real time via super-resolution microscopy, confocal imaging, and live-cell imaging facilities. Such technical innovations upgrade the high content screening systems with better analytical precision and more detailed results in the future, thus the work of identifying cellular processes and response to stimuli becomes more advanced and thorough. Hence, the supply of cleaner and more efficient high content screening systems, incorporating the latest imaging technics is rising which is responsible for the market development.

Rising Investments in Biotechnology Research

The high content screening market revenue is experiencing significant growth due to rising investments in biotechnology around the world. As per Biotechnology Innovation Organization (BIO), global spending on biotechnological R&D exceeded $210 billion in 2020 showing the investments made in advancing scientific knowledge as well as development of new therapeutic options. High content screening takes a central position in biotechnology research by speeding up the investigating process of wondering what the cells do and the interactions among the molecules. Biotech firms and research institutions utilizing new discovery targets for drug development, as well as assessing compound efficacy and toxicity, and elucidating disease mechanisms are some of the factors driving an increased high content screening market demand. As a result, this tendency will lead to market growth and further research on high content screening techniques will be done.

High Content Screening Market Segmentation:

Breakup by Product:

Instruments
- Cell Imaging and Analysis Systems
- Flow Cytometers
Consumables
- Reagents & Assay Kits
- Microplates
- Others
Software
Services
Accessories

Instruments accounts for the majority of the market share

Instruments dominate the market by assuring a precise and effective cellular analysis that leads to discovery of drugs and research. For instance, NIH projections forecast that the figures for worldwide purchases of the research equipment and instrumentation will pass $53 billion mark by 2025. This high magnitude investment thus accounts to the increasing demand for up-to-date technology equipment in biomedical research with high content screening instruments. However, major pharmaceutical and biotechnology firms have introduced screening platforms technologies in which drug discovery processes are accelerated that will lead to huge growth of high content screening instruments. As a result, those engaged in the manufacture of instruments are shifting their attention towards creating more modern tools that offer better imaging, automation, and data analysis features to satisfy the demand of scientists who are always looking for something new.

Breakup by Application:

Target Identification and Validation
Primary Screening and Secondary Screening
Toxicity Studies
Compound Profiling
Others

Primary screening and secondary screening hold the largest share of the industry

Primary screening and secondary screening dominate the market due to the rising urgency of accelerating the drug discovery process. According to data from NIH, the global pharmaceutical industry is experiencing an accelerated growth and is expected to reach an estimate of $1,200 billion in sales in 2024. This is a leverage to invest in high content screening technologies for primary screening, as the ability to evaluate large amounts of compound libraries to identify potential drug candidates quickly becomes automated and systematic. Afterward, cell-based assays are indispensable for following up on hit compounds in the secondary screening step, characterizing their efficacy, safety, and mechanism of action. This accelerates primary and secondary high content screening solutions adoption.

Breakup by End-User:

Pharmaceutical and Biotechnology Companies
Academic and Government Institutes
Contract Research Organizations (CROs)

Pharmaceutical and biotechnology companies represent the leading market segment

Pharmaceutical and biotechnology firms are driven by the basic necessity to speed up drug discovery or development in the field of market. As per the National Institutes of Health (NIH), the global drugs industry is anticipated to go beyond 1.5 trillion dollars by the year 2025. This abundant market chance therefore entices firms to invest in the state-of-the-art screening technologies to screen drug candidates swiftly. Moreover, high-content screening allows drug and biotechnology companies to perform in-depth cellular assays, thus enabling the evaluation of drug candidates' effectiveness and side-effect profiles. With the use of high content screening methods, these companies can essentially automate their research workflow and therefore shorten development timelines to bring novel treatments to the market faster. Furthermore, progress in imaging technology and data analysis algorithms adds to the power of high content screening platforms to the discovery of unsuspected life behaviors and disease mechanisms. Thus, investments of pharmaceutical and biotechnology companies in the development of high content screening run high leading to innovation and improvement of patient outcome.

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest high content screening market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for high content screening.

North America dominates the market due to the provision of massive government grant to biomedical industry. For instance, the National Institutes of Health or NIH reported that the US government covers up to $30 billion in its yearly budget for biomedical research. This sizeable incurred investment, however, stimulates innovation, therefore enhancing the use of more advanced screening technologies resulting in the market development. Further, the area enjoys well-established medicine infrastructure, a cluster of leading research institutes and a labor force with a high level of competence which provide additional prestige to the region in the high content screening market. As result North America stays at the forefront of the equipment used in the pharmaceutical and biological sectors' research and development.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the high content screening industry include Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific and Yokogawa Electric Corporation.
The high content screening market companies are investing in the research and development (R&D) of the product to upgrade the product and broaden the market. Thermo Fisher Scientific, PerkinElmer, and GE Healthcare, amongst others, leading the trend in imaging technologies for high-content screening. For instance, Thermo Fisher Scientific spent around 1.1 billion dollars in 2020 on R&D activities. These investments aim to develop new imaging technologies, automation solutions and software platforms that are capable of driving the growing market and meeting the ever-searching demand for advanced cellular analysis and drug discovery related applications. These businesses are developing microscopy systems with enhanced imaging, automation features, and data analysis algorithms that suit the emerging needs of pharmaceutical and biotechnology scientists in drug development and cellular analysis experiments.

Key Questions Answered in This Report

1.How big is the high content screening market?
2.What is the future outlook of high content screening market?
3.What are the key factors driving the high content screening market?
4.Which region accounts for the largest high content screening market share?
5.Which are the leading companies in the global high content screening market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global High Content Screening Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Major Types
  - 6.1.2.1 Cell Imaging and Analysis Systems
  - 6.1.2.2 Flow Cytometers
- 6.1.3 Market Forecast
6.2 Consumables
- 6.2.1 Market Trends
- 6.2.2 Major Types
  - 6.2.2.1 Reagents & Assay Kits
  - 6.2.2.2 Microplates
  - 6.2.2.3 Others
- 6.2.3 Market Forecast
6.3 Software
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Services
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Accessories
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Target Identification and Validation
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Primary Screening and Secondary Screening
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Toxicity Studies
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Compound Profiling
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by End-User

8.1 Pharmaceutical and Biotechnology Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Academic and Government Institutes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Contract Research Organizations (CROs)
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Becton, Dickinson and Company
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Bio-Rad Laboratories Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Biotek Instruments Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
- 14.3.4 Danaher Corporation
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 GE Healthcare
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Merck Millipore
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Perkinelmer Inc.
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Tecan Group Ltd.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Thermo Fisher Scientific
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Yokogawa Electric Corporation
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis

ハイコンテントスクリーニング市場レポート：製品、用途、エンドユーザー、地域別、2025～2033年

High Content Screening Market Report by Product, Application, End-User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations ), and Region 2025-2033

ハイコンテントスクリーニング市場分析：

ハイコンテントスクリーニング市場動向：

創薬需要の増加

イメージング技術の継続的な進歩：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のハイコンテントスクリーニング市場

第6章 市場内訳：製品別

第7章 市場内訳：用途別

第8章 市場内訳：エンドユーザー別

第9章 市場内訳：地域別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格指標

第14章 競合情勢